XML 21 R5.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders’ Equity - USD ($)
Series 1 Convertible Preferred Stock
Series 2 Convertible Preferred Stock
Common Stock
Additional Paid in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 855,955 $ 21,952,000 $ 1,779 $ 35,313,721 $ (48,155,180) $ 9,968,275
Balance (in Shares) at Dec. 31, 2019 171,191 21,952 17,783,960      
Provision for compensation expense related to stock options 981,261 981,261
Provision for compensation expense related to stock options (in Shares)      
Issuance of warrants in connection with consulting agreements 407,494 407,494
Issuance of warrants in connection with consulting agreements (in Shares)      
Exercise of stock options into common stock $ 1 5,661 5,662
Exercise of stock options into common stock (in Shares) 7,166      
Conversion of preferred stock to common stock $ (4,295)     4,295    
Conversion of preferred stock to common stock (in Shares) (859)   1,136      
Exercise of warrants into common stock $ 10 131,240   131,250
Exercise of warrants into common stock (in Shares)     105,000      
Exchange offer of warrants     $ 346 (346)    
Exchange offer of warrants (in Shares)     3,462,683      
Net income (Loss)         (339,896) (339,896)
Balance at Dec. 31, 2020 $ 851,660 $ 21,952,000 $ 2,136 36,843,326 (48,495,076) 11,154,046
Balance (in Shares) at Dec. 31, 2020 170,332 21,952 21,359,945      
Provision for compensation expense related to stock options       1,125,819   1,125,819
Issuance of warrants in connection with consulting agreements       522,808   522,808
Exercise of stock options into common stock $ 8 68,164 68,172
Exercise of stock options into common stock (in Shares) 82,333      
Net income (Loss)         3,272,774 3,272,774
Balance at Dec. 31, 2021 $ 851,660 $ 21,952,000 $ 2,144 $ 38,560,117 $ (45,222,302) $ 16,143,619
Balance (in Shares) at Dec. 31, 2021 170,332 21,952 21,442,278